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In epidermal cell suspensions, prepared from healthy 
human and murine skin, Langerhans cells (LC) were 
identified by indirect immunofluorescence microscopy 
using monoclonal antibodies directed against human T6 
and Ia markers, and against a murine Iak determinant, 
respectively. The cells were double-labeled on cytospin 
slides with antibodies against a cytoskeletal protein, 
either vimentin or keratin. In this way it was shown 
that epidermal LC contain intermediate-sized filaments 
of the vimentin type. 
Membrane markers defined by monoclonal an tibodies a re 
used increasingly more to determine t h e nature of cells. In t his 
way human and murine epidermal LC can be stained by anti-
bodies aga inst class II (la) a nti gens [1- 3). Class II antigens, 
however, can be expressed a lso by ep idermal keratinocytes 
under certa in condi tions, for example, during a delayed-type 
hypersensitivity reaction [4 ,5 ], during graft rejection [6], or by 
specialized epidermal cells in humans [7). For human LC a 
more specific marke r was found in the T6 antigen which is not 
expressed by any other epidermal cell type [8,9). Studies us ing 
bone marrow chimeras have indicated that epi derm al LC a re 
derived from a mobile pool of precursor cells and probably 
origi nate from the bone marrow [10 ,11) . The epidermis there-
fore would consist of cell s from different origins: the keratino-
cytes from epide rmal origi n , and the LC from mesenchymal 
origin. T his difference in origin might be reflected in different 
cytoskeletal constituents , in particular in different types of 
intermediate-sized filam ents [1 2]. Epithelial cells usually con-
tain keratin, whereas mesenchymal cells co ntain vimentin. The 
presence of vimentin -positive dendritic-shaped ce lls in n ormal 
human epidermis was reported rece nt ly [13,14) and ev idence 
was presented that vimentin can be found in human ep idermal 
L C [15]. In the murine epidermis, vimentin -positive dendritic-
shaped ce lls can be observed as well. An important part of these 
cells are t he recently described Thy-1 a ntigen -bearing cells 
[16,17], which represent a cell population separate from LC. 
In this study we investigated t he presence of t he intermediate 
filament proteins vimentin a nd keratin in epidermal cell s us-
pensions of normal human and murine skin . Using double-
labeling immunofluorescence microscopy we demonstrate t he 
prese nce of vimentin in t he ep ide rm al LC of both mouse a nd 
humans, and give a quantitation of the number of these cell s 
present. Our findings point to a mesenchymal origin of the LC, 
and are in support of its suggested bone marrow origin . 
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Abbrev iations: 
BSA: bovine serum albumin 
II F: indirect immuno11uorescence 
LC: Langerhans cell(s) 
PBS: phosphate-buffered saline 
MATERIALS AND METHODS 
Antibodies 
Rabbit anti keratin and rabbit antiviment in antibodies were prepared 
as described previously [18,19]. Monoclonal ant imouse lak ant ibody 
was raised in our laboratory and has been described previously [20]. 
Monoclonal antihuman T3, T6, and !a ant ibodies were purchased from 
Ortho Pharmaceutical Co rporation, Raritan, New Jersey, monoclonal 
anti-Thy 1.2 from New England Nuclear (Dreieich, F.R.G.). 
Cell Suspensions 
Mouse epiderm al cell s were prepared from ta il sk in of A.TL (Iak) or 
B10.D2 (la") donor mice. The skin was placed in 0.5 % trypsin solut ion 
in phosphate-buffered saline (PBS) at 37oC and incubated for 80 min. 
The epidermis was carefully removed from the underlying dermis and, 
by gentle rubbing with a glass rod, the epidermal cells were placed in 
suspension in RPM! 1.640 medium (Flow Laboratories, Irvine, Scot-
land) containing 20 mM Hepes buffer, 10% fetal calf serum, and 0.05% 
DNase I (Boehringer, Mannheim, F.H.G .). The cells were centrifuged 
for 6 min at 200 g, resuspended in PBS containing 1% bovine serum 
albumin (BSA) and 0.1 % sodium azide, and washed tw ice in this last 
solution. The cells were counted in a Burker cou nt ing chamber and 
diluted to a concentration of 5 x lOu cells/mi. Ce ll viabi li ty was 
determined by trypan blue dye exclusion, and always equalled more 
than 95%. 
Human epidermal cells were isolated from healthy skin, obtained 
from mastectomies, in essentially t he same way as the murine cells, 
except for an incubation t ime in t rypsin of 150 min. 
Cytocen.tri(uge Preparations 
For the preparation of cytocentrifuge sl ides 25 ~tl of a cell suspension 
of 2 x 106 cell s/ml in PBS containing 4.5% BSA, 0.5% EDTA, and 
0.1 % sodium azide were used. Slides were spun off at 200 g for 5 min, 
air-dried, and fixed in 100% acetone for 3 min. 
J mm.un.ofluorescence 
Indirect immunofluorescence (IIF) for the detection of membrane 
markers was carried out on cell suspensions, llF for t he detection of 
cyt.oskeleta l proteins on cytocentri fuge slides. Antibody di lutions and 
incubation t imes were as described previously 118,20] or as recom-
mended by the manufacturer. The specificity of the antisera was 
controlled carefully: in particular the absence of reactivity of the 
anti mouse lg conjugate with rabbit lg, and of the anti rabbit lg conjugate 
with mouse lg, swine lg, goat lg, and avidin was verified. 
RESULTS 
An epidermal cell suspension was prepared from healt h y 
human sk in, and a liquots of these ce lls were incubated with 
di lutions of OKT6, OKIA, OKT3, and antimouse Iak mono-
clonal an tibody, and sta ined with a fluorescein-conjugated sec-
ond laye r. From these labeled ce ll suspens ions, cytospin slides 
were prepared a nd double-labeled with eit her an t ikeratin or 
TABLE 1. Quanlitation of cells in the epidermis that bear the ! a, T6, or 
Thy- / marher, or contain. the uim.entin intermediate filament 
Percentage of lola I cell number ± SD 
Sk in source 
------
Vimenlin Ia T6 Thy-1 
---
Human breast 5.9 ± 1.5 3.7 ± 1.4 4.2 ± 1.2 
Murine ta il 2.2 ± 0.5 0.6 ± 0.2 2.0 ± 0.9 
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Frr. 1. Double- labeling immunofluo-
rescence micrographs showing t he reac -
tions of OKT6, labeled indirectly wi th 
fluorescein isothiocyanate (FITC) , a nd 
a n t ibodies against keratin or vimentin , 
labeled indirectly with tetramethylrho-
d a rnin e isothiocyanate (TRITC) , on cy-
toce n t rif"uge preparations of a huma n ep-
ide rmal cell suspension. a., Reaction with 
oKT6. b, Same cell s as seen in (a) la-
beled with a ntikeratin. c, Reaction wi t h 
OKT6. d, Same cells as seen in (c), la-
beled with a ntivimentin . Original mag-
ni f ication X 78. 
vimentin a ntibodies that were developed with a rhodamine 
conjugate. The percentage of ce lls that were positive for Ia, T6, 
or vimentin was determined and the resul ts are shown m Table 
I. All Ia+ and TG+ cells had a dendritic appearance, were positive 
for vimentin and negative for keratin (Fig 1). No binding of 
OKT3 or antimouse Iak was obse rved. 
Simi lar experiments were performed with ce lls from mouse 
ta il s kin. Epidermal cell suspensions from skin of A.TL (Iak ) 
and B10.0 2 (IacJ) mice were prepared and a liquots were incu-
bated with dilutions of OKia, antimouse Iak, or ant i-Thy 1.2 
monoclona l antibody. Subsequently, cytospin slides were pre-
pared and the ce lls double-labeled wi t h. ~nti~imenkti~ and ker-
atin a ntibodies. The ce ll s that were positive for Ia , lor vunen-
t in a nd for Thy- 1.2 were counted (Table 1) . Ia+ and T hy 1 + 
de~dritic-shaped ce ll s were inva riably a lso vimentin+ and ker-
atin - . B 10.02 epidermal cell s se rved as a spec ificity control for 
t he anti-fak antibody. No binding of the anti-lak to t he vimen-
t in+ BlO.D2 epidermal cell s was observed. Binding of OKia 
wit h mouse epidermal cells was not observed for the A.TL or 
for t h e B10.D2 strain. 
DISCUSSION 
In t hi s study epidermal ce ll s were studied using cell suspen-
sions a nd cytospin preparations. In this way single cells can be 
st udie d, which present a clearer image compared to frozen t issue 
sections where the preparat ion often consists of several layers 
of adjacent ce lls, and it enables one to provide a quantitation 
of a certain cell type as a fract ion of t he total number of cells 
present. 
Our results show that human dendri t ic-shaped epidermal 
cells, t hat bea r the la and T 6 markers, contain the intermediate 
fi la m e nt vimentin . Since the TG marker is exclusively expressed 
in t h e epidermis on LC, we conclude that human LC conta in 
virnentin and lack kerat in. T able I shows that the ra+ and TG+ 
ce lls occm in approximately equal numbers. We therefore as-
sume that t he expression of Ia- like ant igens is restricted to LC 
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in our suspensions. Accordingly, no Ia+ keratinocytes we re 
observed, alt hough it is known t hat these cells can express Ia 
[7,21]. A number of vimentin+ cells did not express t he Ia or 
TG marker (rul.9 %). This fraction consists , at least in part, of 
melanocytes, which a re also known to conta in vimentin [13], 
but other ce ll types can be present as well. 
In normal mouse skin epidermis, l a antigen expression is 
restricted to LC [3]. This cell occurs in low amounts in tail 
skin [22], which is in agreement with the low percentage ofiA + 
cells found by us (Table I) . All la+ cells are vimentin+ a nd we 
conclude t hat murine LC contain t he vimentin filament. Again, 
a number of vimentin+ cells did not express Ia surface markers 
but, usi ng a monoclonal ant ibody against the Thy-1.2 antigen: 
we demonstrated t he presence of Thy-1"' dendri t ic-shaped cells 
in 2.0 % of t he total cell number. These recent ly described cell s 
a lso contain vimentin [1 6,17] and their discO\;ery provides an 
explanation for t he considerable number of vimentin+ ra- cells 
in our suspensions of mouse tail skin cells. 
The origin of the ep idermal LC has been t he subject of severa l 
studies (for a review, see [23]) , in particular after t he demon-
stration of la ant igens on the membrane of these cells [1,2]. l t 
was assumed that t hey are part of a mobile ce ll pool and 
probably originate in t he bone marrow [10,11]. Our findings 
that LC contain intermediate fi laments of the vimentin type is 
in agreement with this assumption. 
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